(2023)
Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia.
Blood Research.
1,
1
(2023)
Current Status and Physicians' Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists.
JOURNAL OF KOREAN MEDICAL SCIENCE.
38,
29
(2023)
Methionine metabolism and endocrine function of the pituitary gland in patients with suprasellar germinoma.
PLOS ONE.
18,
7
(2023)
High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma.
PEDIATRIC BLOOD & CANCER.
70,
4
(2023)
Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency.
CLINICAL IMMUNOLOGY.
(2023)
Self‑reported physical activity behaviors of childhood cancer survivors: comparison to a general adolescent population in Korea.
SUPPORTIVE CARE IN CANCER.
(2022)
Postchemotherapy gross residual tumor in non-high-risk neuroblastoma: Clinical significance and the role of adjuvant therapy.
PEDIATRIC BLOOD & CANCER.
69,
11
(2022)
EPIDEMIOLOGIC AND CLINICAL OUTCOMES OF PEDIATRIC RENAL TUMORS IN KOREA: A RETROSPECTIVE ANALYSIS OF THE KOREAN PEDIATRIC HEMATOLOGY AND ONCOLOGY GROUP (KPHOG) DATA.
PEDIATRIC BLOOD & CANCER.
69,
1
(2022)
Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma.
SCIENTIFIC REPORTS.
12,
1
(2022)
Dual role of ERK2/NF-kappa B signaling in TRAIL sensitivity.
AMERICAN JOURNAL OF CANCER RESEARCH.
12,
7
(2022)
Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY.
44,
2
(2022)
Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies With Clinical Risk Stratification.
JOURNAL OF KOREAN MEDICAL SCIENCE.
37,
7
(2022)
Value of C-11 methionine PET/CT in patients with intracranial germinoma.
PLOS ONE.
17,
2
(2022)
Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma.
CANCER RESEARCH AND TREATMENT.
54,
1
(2022)
Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma.
CANCER RESEARCH AND TREATMENT.
54,
1
(2021)
Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
PEDIATRIC BLOOD & CANCER.
1,
1
(2021)
Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants.
ANNALS OF HEMATOLOGY.
101,
2
(2021)
Application of an LC-MS/MS Method for the Simultaneous Quantification of Homovanillic Acid and Vanillylmandelic Acid for the Diagnosis and Follow-Up of Neuroblastoma in 357 Patients.
MOLECULES.
26,
11
(2021)
Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia.
JOURNAL OF KOREAN MEDICAL SCIENCE.
36,
19
(2021)
Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
CANCER RESEARCH AND TREATMENT.
53,
2
학술회의논문
(2023)
Germline Functional Variants Contribute to Somatic Mutation and Outcomes in Neuroblastoma.
대한소아청소년과학회 추계학술대회.
대한민국
(2023)
HRAS 돌연변이의 체세포 모자이크 현상(Somatic Mosaiclsm of HRAS Mutation)으로 인한 소아의 횡문근 육종 증례.
대한소아청소년과학회 추계학술대회.
대한민국
(2023)
두개 내 배세포종 치료 시 관해유도 항암요법의 강화를 통한 방사선치료 선량의 감소: SMC G-18 연구의 예비 보고.
대한소아청소년과학회 추계학술대회.
대한민국
(2023)
영아 수모세포종의 치료 결과 및 예후 인자 분석 : 대한소아혈액종양학회(KPHOG) 뇌종양위원회 다기관 후향적 연구.
대한소아청소년과학회 추계학술대회.
대한민국
(2022)
단일 센터의 소아 급성림프구성 백혈병 치료 후 생존자의 장기간 성장 결과.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
Response-Adapted Consolidation Therapy Strategy for Patients With Metastatic High-Risk Neuroblastoma: Results From the SMC NB-214 Study.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
Survival of children with acute lymphoblastic leukemia with risk group based protocol change : A 20-year study of 461 patients.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
Treatment of relapsed leukemia without second hematopoietic stem cell transplantation.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
Treatment outcome and prognostic factors of relapsed/refractory pediatric acute myelold leukemia.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
국내 소아 암환자 및 보호자들의 COVID_19 백신졉종 현황 조사.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
재발한 신경모세포종 환자에서 시행한 고용량 131-I MIBG 치료 및 αβ T 세포 제거 반일치 동종조혈모세포이식 결과 분석.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
필라델피아 염색체 양성 급성림프모구백혈병으로 진단 되었던 모세포위기 만성골수성 백혈병 환자 2례.
제72차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2022)
Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin and Low Dose Post-Transplant Cyclophosphamide - A Single Center Retrospective Study.
SIOP 2022 (Congress of the International Society of Paediatric Oncology).
스페인
(2022)
PEDIATRICCANCERTREATMENTONTHEVERGEOFCOLLAPSEINSOUTHKOREA;REPORTOFTHEKOREANSOCIETYOFPEDIATRICHEMATOLOGY-ONCOLOGYFORIMPLEMENTINGBETTERPOLICY.
SIOP 2022 (Congress of the International Society of Paediatric Oncology).
스페인
(2021)
Clinical Implication of Residual MIBG-Positive Disease in the Follow-Up of High-Risk Neuroblastoma Treated with Tandem High-Dose Chemotherapy and Autologous Stem Cel Transplantation.
제71차 대한소아청소년과학회 추계학술대회.
대한민국
(2021)
98명의 소아 고형암 환자들을 대상으로 한 생식세포 암소인 유전자 변이 차세대 염기서열 분석 연구: 단일 기관의 경험.
제71차 대한소아청소년과학회 추계학술대회.
대한민국
(2021)
Excellent outcome of pediatric patients with de novo acute myeloid leukemia treated with a stratified strategy based on prognostic groups: A multicenter prospective study (AML 2012).
제71차 대한소아청소년과학회 추계학술대회.
대한민국
(2021)
신경모세포종 환자의 circulating cell-free DNA를 이용한 chromosomal instability 평가 및 임상적 유용성 확인.
제71차 대한소아청소년과학회 추계학술대회.
대한민국
(2021)
재발한 신경모세포종 환자에서 131-I MIBG 치료 및 반일치 동종조혈모세포이식 병합요법의 예후인자.
제71차 대한소아청소년과학회 추계학술대회.
대한민국
(2021)
저위험 혹은 중간위험군 신경모세포종에서 항암치료 후 잔존존양과 후속치료의 임상적 의의.
제71차 대한소아청소년과학회 추계학술대회.
대한민국
